Revenues of 3.78 billion euros in the first quarter for Winfriedchemy.

On May 12th, the German chemical giant Evonik released its first quarter financial report for 2025: sales amounted to 3.78 billion euros, remaining stable year-on-year; adjusted EBITDA was 560 million euros, an increase of 7% year-on-year; free cash flow reached 195 million euros, an increase of 53% year-on-year. Evonik confirmed its full-year earnings target, expecting adjusted EBITDA for 2025 to be between 20 billion and 23 billion euros.